
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Exo84 CRISPR/Cas9 KO Plasmid (h) | sc-403472 | 20 µg | $397.00 | |||
Exo84 HDR Plasmid (h) | sc-403472-HDR | 20 µg | $445.00 |
EXOC8 encodes Exo84, a core subunit of the octameric exocyst complex that mediates tethering of secretory vesicles to specific plasma membrane sites prior to SNARE-dependent fusion. Through interactions with small GTPases and phosphoinositide-rich membranes, Exo84 contributes to polarized exocytosis, membrane remodeling, and delivery of receptors and adhesion molecules that shape cell migration and epithelial polarity. Exocyst activity interfaces with cytoskeletal dynamics and signaling pathways controlling vesicle trafficking, endosomal recycling, and surface proteome composition. Dysregulation of exocyst-dependent trafficking has been linked to altered cell polarity, invasive behavior, and defects in neuronal and immune cell function, making EXOC8 a useful node for mechanistic studies of disease-associated membrane transport phenotypes.
Exo84 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the EXOC8 gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the EXOC8 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, Exo84 HDR Plasmid (h) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined EXOC8 target site.
When co-transfected with Exo84 CRISPR/Cas9 KO Plasmid (h):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the EXOC8 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.